Home         Biography          Research & Publications          Teaching & Training        Urological Resources        Referrals & Contact
Iqbal Shergill       Iqbal Shergill, Consultant Urological Surgeon
      BSc(Hons),MRCS(Eng),FRCS(Urol), FEBU
Tel: 01978 318241     
Mobile: 07976 946282     
Email: uroemerge@yahoo.co.uk     
Consultant Urological Surgeon
NHS Practice
Wrexham Maelor Hospital (Map)

Department of Urology
Croesnewlydd Road
Wrexham
North Wales
LL13 7TD

Private Practice:
Spire Yale Hospital Wrexham (Map)

Wrexham Technology Park
Croesnewydd Road
Wrexham
North Wales
LL13 7YP

The Grosvenor Hospital Chester (Map)
Nuffield Health
Wrexham Road
Chester
Cheshire
CH4 7QP

Spire Abergele Consulting Rooms (Map)
Ground Floor
Priory House
North Wales Business Park
Abergele
Conwy
LL22 8LJ

NHS Secretary:
Miss Hannah Roberts
Tel: 01978 318242
Email: Click Here

Private Secretary:
Miss Emma David
Tel: 01978 318241
Email: Click Here



Bladder Cancer Cystoscopy
Bladder Cancer (Cystoscopy)

Haematuria (Blood in Urine)
Haematuria (Blood in Urine)

Stress and Urge Incontinence (Female Bladder Problems)
Stress and Urge Incontinence (Female Bladder Problems)

Kidney Stone Diagnosis
Kidney Stone Diagnosis

Kidney Stone Removal after Surgery
Kidney Stone Removal after Surgery

Suspected Prostate Cancer for Raised PSA Blood Test
Suspected Prostate Cancer for Raised PSA Blood Test

Prostate Cancer Investigation
Prostate Cancer Investigation

Mag 3 Renogram Urinary Obstruction
Mag 3 Renogram Urinary Obstruction

MRI Showing Spinal Cord Compression
MRI Showing Spinal Cord Compression

Cook Resonance Metallic Ureteric Stents
Cook Resonance Metallic Ureteric Stents - to aid in the long-term management of urinary tract obstruction

Ascending Cystogram
Ascending Cystogram

JJ Stent for Ureteric Obstruction
JJ Stent for Ureteric Obstruction

Urine Dipstix Testing in Clinic
Urine Dipstix Testing in Clinic

Urine Dipstix Testing in Clinic
PCA3 Urine Test is easy to perform as an outpatient diagnostic test for prostate cancer

Urine Dipstix Testing in Clinic
PCA3 Urine Test results allow stratification of risk for prostate cancer and need for biopsy

Varicocoele
Varicocoele

Embolisation of Varicocoele
Embolisation of Varicocoele

Bladder Tumour at Cystoscopy
Bladder Tumour at Cystoscopy

Calyceal Stone
Calyceal Stone

The first use of ISIRIS (Coloplast) in Wales - single use flexible cytsoscopy stent removal at Wrexham Urology
The first use of ISIRIS (Coloplast) in Wales - single use flexible cytsoscopy stent removal at Wrexham Urology

.
Welcome...!
Croeso...!


Professor Iqbal Shergill, Consultant Urological Surgeon is delighted to warmly welcome you to his website!

This website aims to inform all patients and healthcare professionals about the practice of Urology, by Professor Shergill, in Wrexham, North Wales, as well as Chester, Cheshire and North West England.

Urology refers to the medical and surgical treatment of diseases of the urinary tract, including those of the kidney, ureter, bladder and prostate. All diseases of the penis, urethra, scrotum and testicles are dealt with by Urology Consultants, such as Professor Shergill, and this also includes men's health and sexual problems, such as erectile dysfunction (impotence). In addition, urology problems can also affect females, of all ages and Professor Shergill is available for help and advice on all aspects of urology.

Professor Shergill, Consultant Urologist in Wrexham, North Wales, and Urologist in Chester, Cheshire, is delighted to see patients and advise on the following conditions, based upon his expertise in General/Core urology:

  • Prostate problems
    • Lower Urinary Tract Symptoms - LUTS
    • Benign Prostate Hyperplasia - BPH
  • Bladder problems
    • Stress Incontinence
    • Urge Incontinence
    • Overactive Bladder - OAB
    • Bladder Pain Syndrome / Interstitial Cystitis
  • Rapid access Diagnostic Urology
  • Men's Health Check
    • Raised PSA
    • Suspected Prostate Cancer
    • Concerns regarding risk of Prostate Cancer
    • Erectile Dysfunction
    • Chronic Prostatitis/Chronic Pelvic Pain Syndrome
  • Haematuria (Blood in the Urine)
    • Suspected Bladder Cancer
    • Suspected Kidney Cancer / Renal Cancer
  • Conditions of the Penis and Foreskin
    • Phimosis and Circumcision requests
    • Frenuloplasty requests
    • Peyronies Disease
  • Conditions of the Scrotum
    • Suspected Testicular Cancer
    • Testicular Pain
    • Hydrocoele
    • Varicocoele
    • Epididymal Cysts
    • Undescended Testes
  • Urinary Tract Infections
  • All Urological Emergencies
    • Renal Colic (kidney stones)
    • Acute Urinary Retention
    • Testicular Torsion
    • Urinary Tract Trauma
    • Urethral and Suprapubic Catheter related problems

In addition, Professor Shergill has been specially trained in, and has a super-specialist interest in the following fields of urology:

  • Prostate cancer diagnosis and treatment
    • Multiparametric MRI Prostate
    • Transperineal template Biopsies of Prostate
    • Focal therapy of Prostate Cancer with HIFU (High Intensity Focused Ultrasound) or Cryotherapy

  • Stone disease of the urinary tract
    • Minimally Invasive Surgical Treatments
    • Percutaneous Nephrolithotomy or PCNL (Keyhole surgery for large kidney stones)
    • Rigid and Flexible Ureterorenoscopy and Laser treatment of renal and ureteric stones
    • Extracorporeal Shockwave Lithotripsy (ESWL)

  • Endourology
    • Treatment of prostate and bladder problems
    • Transurethral Resection of Prostate (TURP)
    • Bipolar TURP (TURIS)
    • Holmium Laser Prostatectomy (HOLEP)
    • Urolift (Prostatic Urethral Lift)


MULTI-DISCIPLINARY TEAMWORKING

Importantly, Professor Shergill recognises the value and importance of effective multi-disciplinary team-working in the overall management of all patients and has published editorial on this Multidisciplinary (MDT) Teamworking. Throughout his research, basic surgical training, higher urological training and now as a Consultant Urologist, he has always worked effectively and enjoys working in the multidisciplinary team.


LATEST NEWS

COMPLIMENT LETTERS

Professor Shergill and his team, aim to provide a professional and personalised approach to patient care, with individualised urological treatment. Here are some recent excerpts of compliments given by patients treated by Professor Shergill.

Compliment 1  |  Compliment 2  |  Compliment 3  |  Compliment 4  |  Compliment 5  |  Compliment 6  |  Compliment 7  |  Compliment 8  |  Compliment 9  |  Compliment 10  |  Compliment 11  |  Compliment 12  |  Compliment 13  |  Compliment 14  |  Compliment 15  |  Compliment 16  |  Compliment 17  |  Compliment 18  |  Compliment 19  |  Compliment 20  |  Compliment 21  |  Compliment 22  |  Compliment 23  |  Compliment 24  |  Compliment 25  |  Compliment 26  |  Compliment 27  |  Compliment 28  |  Compliment 29  |  Compliment 30  |  Compliment 31  |  Compliment 32  |  Compliment 33  |  Compliment 34  |  Compliment 35  |  Compliment 36  |  Compliment 37  |  Compliment 38  |  Compliment 39  |  Compliment 40  |  Compliment 41  |  Compliment 42  |  Compliment 43  |  Compliment 44  |  Compliment 45  |  Compliment 46  |  Compliment 47  |  Compliment 48  |  Compliment 49  |  Compliment 50  |  Compliment 51  |  Compliment 52  |  Compliment 53  |  Compliment 54  |  Compliment 55  |  Compliment 56  |  Compliment 57  |  Compliment 58  |  Compliment 59  |  Compliment 60  |  Compliment 61  |  Compliment 62  |  Compliment 63  |  Compliment 64  |  Compliment 65  |  Compliment 66  |  Compliment 67  |  Compliment 68  |  Compliment 69  |  Compliment 70  |  Compliment 71  |  Compliment 72  |  Compliment 73  |  Compliment 74  |  Compliment 75  |  Compliment 76  |  Compliment 77  |  Compliment 78  |  Compliment 79  |  Compliment 80  |  Compliment 81  |  Compliment 82  |  Compliment 83  |  Compliment 84  |  Compliment 85  |  Compliment 86  |  Compliment 87  |  Compliment 88  |  Compliment 89  |  Compliment 90  |  Compliment 91  |  Compliment 92  |  Compliment 93


PROFESSOR SHERGILL IS RUNNING THE CARDIFF HALF MARATHON FOR CHARITY

Professor Shergill and his colleague Professor Stephen Hughes (Principal Research Fellow BCUHB and Scientific Director North Wales and North West Urological Research Centre) will be running the Cardiff 1/2 Marathon. They are hoping to raise as much money along the way to help with the development of the North Wales Clinical Research Centre (NWCRC), which will be based at Wrexham Maelor Hospital, North Wales.

This new research centre is fully supported by Besti Cadwaladr University Health Board, and will be up and running in 2018. It will provide a world class facility for clinicians, nurses and scientists to undertake research into conditions, such as cancer, diabetes, heart disease, and neuro-degenerative disorders (e.g. dementia).

Monies raised for this worthwhile cause will be done via your donations to Awyr Las (Fund: 7N34) via the JustGiving website.


PROMIS TRIAL RESULTS ARE AVAILABLE INVESTIGATING ROLE OF MP-MRI IN PATIENTS SUPECTED TO HAVE PROSTATE CANCER

New research has proved to be a 'game changer' when it comes to diagnosing prostate cancer. Professor Shergill, at Wrexham Maelor University was one of 11 hospitals from across England and Wales who took part in the Prostate MRI imaging study(PROMIS) to discover how best to diagnose prostate cancer. The PROMIS clinical trial has discovered that carrying out a multi-parametric MRI scan first can help some men avoid having a biopsy altogether.

The results from the study showed 27% of men did not need a biopsy at all and 93% of aggressive cancers were detected by using the MRI scan to guide the biopsy compared with just 48% when the biopsy was done at random. Professor Iqbal Shergill, said: "The PROMIS study was a UK wide trial and involved 11 centres throughout the UK, including Wrexham Maelor Hospital, and what it looked at was whether or not we could use MRI scans prior to biopsy for patients who are suspected of prostate cancer. " The results of the study are a potential game changer for men with prostate problems. The results showed that one in four men who had the MRI scan returned a negative result which meant they avoided having a biopsy. "The problem with a biopsy is that it can be associated with complications and also false results so using a non-invasive method like an MRI scan potentially could change how we practice in the future."

Around 100 men from across north Wales took part in the study which was carried out between May 2012 and December 2015. Professor Shergill said: "I was delighted to be part of this research and I know many of my patients also felt the same way and felt honoured to be taking part in something that could change so many people's lives. I'd like to thank my patients who took part, they have helped us answer an important question about how to diagnose prostate cancer."
The National Institute for Health and Care Excellence (NICE) are now looking at the results of the study and will decide whether to recommend that hospitals offer men with a suspicion of prostate cancer a MRI scan to decide if they need a biopsy.

- PROMIS Summary
- PROMIS Trial Lancet Paper 2017


PROFESSOR SHERGILL OFFERS REVOLUTIONARY 21ST CENTURY SOLUTION TO PATIENTS WITH BENIGN ENLARGED PROSTATE - THE UROLIFT PROCEDURE

UroliftA new, minimally invasive surgical procedure to treat an enlarged prostate, or Benign Prostatic Hyperplasia (BPH), has been successfully completed for the first time by Professor Shergill. The ground-breaking Prostatic Urethral Lift, commonly called the UroLift procedure (www.urolift.com) uses tiny permanent implants to hold back the enlarged prostatic tissue, aiding the flow of urine, as opposed to cutting away parts of the enlarged prostate as in existing surgical procedures. The procedure, requires no overnight stay, little need for catheterisation and has a significantly reduced risk of post-operative complications. Compared to more common surgery to treat an enlarged prostate, it also offers a quicker recovery and improved procedure safety, as well as preservation of sexual function.


PROFESSOR SHERGILL OFFERS FIDUCIAL SEED PLACEMENT FOR PATIENTS UNDERGOING IMAGE GUIDED RADIOTHERAPY FOR PROSTATE CANCER

For patients with prostate cancer, Professor Shergill is now offering insertion of fiducial gold seeds (Simon put in images below) prior to radiotherapy treatment. The gold seeds are the size of a grain of rice, and stay permanently in the prostate. The procedure to insert then gold seeds takes approximately 5-10 minutes only, and Professor Shergill would be delighted to see you to consider this treatment. The fiducial seeds then allow image guided radiotherapy which is a more accurate form of treatment, associated with fewer side effects.

Fiducial Seeds  Fiducial Seeds



PROFESSOR SHERGILL IS CLINICAL DIRECTOR OF NORTH WALES AND NORTH WEST UROLOGICAL RESEARCH CENTRE (NW2URC) AND BECOMES HONORARY SENIOR LECTURER AT UNIVERSITY OF CHESTER

Professor Shergill has recently established The North Wales and North West Urological Research Centre (NW2URC - www.nw2urc.com) in conjunction with Professor Stephen Fôn Hughes (Principal Research Fellow at BCUHB and previously, Senior Lecturer and Programme Leader BSc (Hons) Biomedical Science at University of Chester). This is a clinical and basic science collaboration between Wrexham Maelor Hospital, the University of Chester and Glyndwr University. The studies are potentially ground-breaking, assessing novel biomarker profiles to predict post-operative complications, clinical outcome and to predict cancer recurrence and progression (European Urology Congress 2014 Presentation). In the NW2URC, new clinical research fellows have registered research projects for PhD and Masters degrees. The new NW2URC lab is now open at Wrexham Maelor hospital site (See photos here).


PROFESSOR SHERGILL IS ELECTED ONTO BAUS SECTION OF ACADEMIC UROLOGY COMMITTEE

Professor Shergill has recently been elected to the British Association of Urological Surgeons (BAUS) Section of Academic Urology Executive Committee. The Section of Academic Urology was formed in June 2007 with the aim of promoting the development and expansion of high-quality, academic urology. It also aims to act as a forum for discussion of practical issues relating to clinical research, in association with academic clinicians in UK urology departments and in other units. See BAUS Section of Academic Urology.


PROFESSOR SHERGILL IS PRINCIPAL INVESTIGATOR IN NEW CLINICAL RESEARCH TRIALS IN UROLOGY BASED AT WREXHAM

Professor Shergill is the Principal Investigator in several national and international multi-centre clinical research trials in urology. These include the following:
  1. INDEX Trial - This is a National Cancer Research Network (NCRN) multi-centre prospective trial evaluating Focal Therapy using High Intensity Focused Ultrasound for the treatment of localised prostate cancer. Wrexham is the only centre in Wales and North West England, and the trial is also being performed in conjunction with UCLH London, Imperial College Healthcare NHS Trust, Oxford Radcliffe Hospitals NHS Trust, University Hospitals Bristol NHS Foundation Trust and Royal Marsden NHS Foundation Trust.
  2. PROMIS Trial - This is a Medical Research Council (MRC PR11) multi-centre trial investigating the use of multi-parametric Magnetic Resonance Imaging (MP-MRI) as a tool in the diagnosis of prostate cancer. The PROMIS aims to evaluate whether MP-MRI improves the ability to detect as well as rule-out clinically significant prostate cancer in a group of men currently advised to have prostate biopsy. Wrexham is the only centre in Wales and North West England.
  3. SURTIME Trial - This is an EORTC (European Organisation for Research and Treatment of Cancer) randomized Phase III trial comparing immediate versus deferred nephrectomy in patients with synchronous metastatic renal cell carcinoma. The principal objective of the trial is to investigate whether the sequence of the nephrectomy in patients who receive sunitinib has an effect on patient outcome.
  4. COMPARE Trial - This clinical trial is evaluating patient preferences for the treatment of localized prostate cancer (COMparing treatment options for ProstAte cancer).



PROFESSOR SHERGILL IS CLINICAL DIRECTOR OF NORTH WALES AND NORTH WEST UROLOGICAL RESEARCH CENTRE (NW2URC) AND BECOMES HONORARY SENIOR LECTURER AT UNIVERSITY OF CHESTER

Professor Shergill has recently established The North Wales and North West Urological Research Centre (NW2URC - http://www.biomedicalcpd.com/#!nw2urc/c1st6) in conjunction with Dr Stephen Fôn Hughes (Senior Lecturer and Programme Leader BSc (Hons) Biomedical Science at University of Chester). This is a clinical and basic science collaboration between Wrexham Maelor Hospital, and the Department of Biological Sciences at the University of Chester. The studies are potentially ground-breaking, assessing novel biomarker profiles to predict post-operative complications, clinical outcome and to predict cancer recurrence and progression (European Urology Congress 2014 Presentation). In the NW2URC, new clinical research fellows have registered research projects for PhD and Masters degrees.


PROFESSOR SHERGILL BECOMES FELLOW OF EUROPEAN BOARD OF UROLOGY (FEBU)

Professor Shergill has recently passed the FEBU Urology examination in Brussels.
The European Board of Urology is a section office of the European Union of Medical Specialists (UEMS) and its objectives are to study, promote and harmonise urological training in Europe.
The FEBU examination offers a systematic assessment for the recognition of quality and is recognised internationally as a Mark of Excellence in Urology.


CYSTINURIA EDUCATIONAL EVENING

An inaugural meeting of patients with Cystinuria and clinicians diagnosing, treating and managing Cystine Kidney Stones in North Wales and Cheshire was held recently.
Please click here to find out more information about this event.


HIFU TREATMENT (MINIMALLY INVASIVE ULTRASOUND TREATMENT FOR PROSTATE CANCER) NOW AVAILABLE IN WREXHAM, NORTH WALES AND CHESTER, CHESHIRE

Professor Shergill, and his team at the Spire Yale hospital, are the first clinical team in Wales to offer HIFU treatment for prostate cancer patients. HIFU (High Intensity Focused Ultrasound) is a minimally invasive therapy option for localised prostate cancer that may offer a balance between eliminating cancer and maintaining quality of life. With HIFU treatment, precisely focused ultrasound waves that, when delivered, raise the temperature of the targeted prostate tissue to 80-90 degrees Celsius in 2-3 seconds. This rapid-firing heat destroys the targeted tissue while leaving healthy structures outside the prostate gland unharmed. Importantly, there are different types of HIFU treatment, allowing focal therapy of prostate cancer cells, in some patients, leaving "normal" prostate gland tissue alone - thus reducing risk of side effects.

Professor Shergill can now offer this very effective treatment, at the Spire Yale hospital. HIFU involves a short operation under general anaesthetic, performed as a one-day case procedure, in virtually all patients. It is a very safe procedure with minimal risks at time of operation and recovery afterwards is usually very quick. Importantly, HIFU is associated with good cancer control and minimal side effects, such as erection problems and incontinence, which commonly occur with radical surgery and radiotherapy treatments. Finally, as HIFU uses an energy source which is not associated with radiation, the procedure can be subsequently repeated, if necessary, again with excellent results, allowing men to have continued treatment with excellent quality of life.

Recently, as reported on Sky News, BBC News and the national newspapers, research has shown that prostate cancer can now be treated effectively with HIFU, importantly, with very minimal incontinence and impotence rates. There is a 9 in 10 chance of achieving excellent clinical results at 12 months with no urine leak, good erections and no imaging evidence of disease recurrence. Essentially, these results are very encouraging and demonstrate that HIFU provides an alternative to traditional prostate cancer treatments with fewer side effects, which could mean a significant improvement in the quality of life for patients.



PROSTATE MAPPING (TRANSPERINEAL TEMPLATE BIOPSIES OF THE PROSTATE) ALSO NOW AVAILABLE IN WREXHAM, NORTH WALES AND CHESTER, CHESHIRE

Professor Shergill, and his team at the Spire Yale are now offering Prostate Mapping (Transperineal Template biopsies of the prostate). In this technique multiple cores from the prostate are taken through the perineum. This procedure is performed under GA, utilising a trans rectal probe for localisation and a stepper unit to site the needle.

Due to the more accurate and more complete sampling of the gland a cancer detection rate of 78% is reported. Prostate Mapping (Transperineal Template biopsies of the prostate) is the 21st Century way of accurately assessing and mapping the prostate compared with the standard prostate biopsy.

It has been found extremely valuable for the following groups of patients:

1. Previous negative prostate biopsy with raised PSA. This will allow a definitive answer without the need for multiple repeat standard prostate biopsies or prolonged outpatient follow up.

2. Prior to Active Surveillance of prostate cancer.

3. Prior to HIFU treatment - as it allows one to differentitate which patients need whole gland treatment, hemi-gland treatment or focal therapy of the prostate cancer only.

4. Patients with a high risk of sepsis, as the risk of sepsis with Prostate Mapping (Transperineal Template biopsies of the prostate) is virtually nil.

NEW UROLOGY LASER AT WREXHAM MAELOR HOSPITAL

In their efforts to establish world class stone and endourological services at Wrexham Maelor Hospital, Professor Shergill and his colleagues have recently obtained a state-of-the art Laser system, for the treatment of all forms of kidney stones.
The Laser system has been purchased from a generous donation by Maelor Voluntary Services and it is widely anticipated that a wide range of benefits for patients will be achieved, including: Improved overall quality of treatment for patients, reduced need for multiple treatments, reduced need for multiple admissions, patients not requiring referral to hospitals outside Wrexham, virtually all procedures can be performed as Day Cases, reduced rates of postoperative discomfort, quicker return to work and normal activities, fewer complications (particularly useful in the large group of Jehovah's Witness patients and elderly patients on blood thinning medications who are increasingly developing kidney stones) and finally higher patient satisfaction rates, as patients receive modern 21st Century urological surgery.

Indeed, in addition to providing 21st Century surgical treatment of urological stone disease, other urological diseases, including bladder cancer and some forms of early kidney cancer, can be treated with this Laser system.

In summary, with the recent acquisition of this laser system, Professor Shergill and his colleagues will be able to provide comprehensive state-of-the art 21st century care for urology patients in North Wales, and it is expected that "No urological stone will be left unturned in Wrexham!"

HONORARY CLINICAL TEACHER - CARDIFF UNIVERSITY SCHOOL OF MEDICINE - Click Here


BMA BOOK AWARD NOMINATION - Click Here


KIDNEY STONES ARTICLE IN DAILY POST PAPER

Professor Shergill has published two articles on kidney stones in the local Daily Post newspaper View here for Article on Kidney Stones Assessment and View here for Article on Laser treatment.

WELSH CORE SURGICAL TRAINEE OF THE YEAR 2011

One of Professor Shergill's Core Surgical Trainees has received the "Best Welsh Core Surgical Trainee Award 2011" for his surgical training portfolio, whilst at Wrexham Maelor Hospital urology department. View

PCA3 URINE TEST FOR SUSPECTED PROSTATE CANCER NOW AVAILABLE IN WREXHAM

Prostate cancer is one of the most frequently diagnosed cancers in men. The PCA3 Urine Test is a new gene-based test to aid in the diagnosis and treatment of prostate cancer, for all men, and the latest news is that Professor Shergill now offers this test at Spire Yale Hospital, Wrexham (View Patient Information Leaflet).

In this test, a urine sample is collected following an examination of the prostate for the determination of the PCA3 Score. Imprtantly, PCA3 is specific for prostate cancer and, unlike the normally used PSA blood test, not affected by prostate enlargement or other non-cancerous prostate conditions. The urine sample is analysed by a highly specialised laboratory and within 1-2 weeks, Professor Shergill will receive your PCA3 Score and advise you on further management of your condition.

MENS HEALTH CHECK (PROSTATE AND MALE SEXUAL HEALTH CLINIC) AT SPIRE YALE HOSPITAL

Professor Shergill and his dedicated multi disciplinary team at the Spire Yale Hospital, Wrexham, have introduced an innovative new Men's Health Check clinic (View Men's Health Clinic Flyer).
In this clinic, Professor Shergill and the Spire Yale Hospital, offer a totally inclusive complete care package, involving full assessment, examination, blood tests and bladder/prostate scans (View Men's Health Clinic Information Sheet).
In addition, a PCA3 urine test can be offered as well (see above) for further peace of mind.

For further information or to book an initial consultation and assessment, please call Spire customer services 01978 262462 or 01978 208035.

Alternatively, please e-mail Cerys Parry (Customer Service Manager0, or Michelle Dodd (Customer Service Advisor) on info@spireyale.com
Clinic Times

Monday AM
Stone clinic And General Urology Clinic
Deeside Community Hospital and Chirk Community Hospital

Tuesday PM
Flexible Cystoscopy and Haematuria Clinic

Wednesday AM
ESWL

Thursday PM
One-stop Rapid Access Diagnostic Urology Clinic
Oncology Follow Up Clinic
Emergency and Urgent Referrals Clinic



Operating Sessions

Tuesday AM
Day Case Operating Theatre

Tuesday PM
Main Inpatient Operating Theatre

Wednesday AM and PM
Main Inpatient Operating Theatre



Multidisciplinary Team Meetings (MDT)

Tuesday PM
Oncology MDT

Thursday PM
Stone and Endourology MDT Forum

Wednesday PM
Nephrology/Urology MDT (KUB Meeting)

Thursday PM
Continence Forum



Prostate Cancer Diagnosis
Prostate Cancer Diagnosis

Prostate Cancer Treatment
Prostate Cancer Treatment

Prostate Health Check
Prostate Health Check

Rapid Diagnostic Urology Investigations 1
Rapid Diagnostic Urology Investigations 1

Rapid Diagnostic Urology Investigations 2
Rapid Diagnostic Urology Investigations 2

Testicular (Scrotal) Lump
Testicular (Scrotal) Lump

Urodynamics (VCMG)
Urodynamics (VCMG)

3 Way Catheter
Urethral and Suprapubic Catheter related problems

Emergency CT scan showing Left Kidney Stone
Emergency CT scan showing Left Kidney Stone

Kidney stone resistant to Shockwave Lithotripsy (ESWL) and awaiting Flexible Ureterorenoscopy (URS) and Laser Lithotripsy
Kidney stone resistant to Shockwave Lithotripsy (ESWL) and awaiting Flexible Ureterorenoscopy (URS) and Laser Lithotripsy

Large Bladder Stone in Neuropathic Bladder Patient
Large Bladder Stone in Neuropathic Bladder Patient

JJ Stent on XRay Image
JJ Stent on XRay Image

Urethral stricture image at Flexible Cystoscopy
Urethral stricture image at Flexible Cystoscopy

Urethrogram Showing Urethral Stricture
Urethrogram Showing Urethral Stricture

Ultrasound Scan Showing Large Hydrocoeles
Ultrasound Scan Showing Large Hydrocoeles

Ultrasound Scan Showing Epididymal Cyst
Ultrasound Scan Showing Epididymal Cyst

Prostate Cancer HIFU Treatment Explained
Prostate Cancer HIFU Treatment Explained

Prostate Cancer HIFU Treatment
Prostate Cancer HIFU Treatment

Sonablate HIFU Prostate Probe and Machine
Sonablate HIFU Prostate Probe and Machine

Focal Therapy (HIFU) for Prostate Cancer Focal Therapy (HIFU) for Prostate Cancer

Urology in Wrexham | Urology in North Wales | Urology in Chester | Urology in Cheshire | Urology in North West England | Private Urologist in Wrexham | Private Urologist in North Wales | Private Urologist in Chester | Private Urologist in Cheshire | Private Urologist in North West England | Kidney Stones North Wales, Chester and Cheshire | PCNL, Flexi URS and Laser | ESWL North Wales Chester and Cheshire | Keyhole surgery North Wales, Chester and Cheshire | Laparoscopy North Wales, Chester and Cheshire | Laser prostatectomy Prostate Surgery | North Wales, Chester and Cheshire | Men's health check Wrexham | Chester and Cheshire | HIFU High Intensity Focussed Ultrasound Ultrasonics Prostate Cancer Wrexham, Chester and Cheshire | Transperineal Saturation Template Prostate Biopsy Biopsies | Manchester | Liverpool | Northwich | Crewe | Conwy | Rhyl | Colwyn Bay | Deganwy | Llandudno | Abergele | Prestatyn | Denbighshire | Anglesey | Bangor | Menai Bridge | Caernarfon | Blaenau Ffestiniog | Betws-y-Coed | Corwen | Bala | Porthmadog | Dolgellau | Barmouth | Powys | Welshpool | Newtown | Llangollen | Shrewsbury | Oswestry | Chirk | Overton | Ellesmere | Ellesmere Port | Telford | Whitchurch | Malpas | Buckley | Connahs Quay | Ewloe | Deeside | Queensferry | Hawarden | Northop | Northop Hall | Bagillt | Holywell | Mold | Cilcain | Penyffordd | Broughton | Shotton | Airbus | Rossett | Gresford | Belgrave | Lache | Christleton | Rowton | Mickle Trafford | Aldford | Waverton | Farndon | Tarvin | Tarporley | Cuddington | Clotton | Delamere | Kelsall | Winsford | Middlewich | Warrington | AxaPPP | Aviva |BUPA | Prudential | PruHealth | WPA | Alliance Surgical | Norwich Union |Saga | Passport2Health | Healthfund | Benenden | Freedom Health | Exeter Family Friendly | Right to Health | Healthtrust | Drewberry |SJS Healthcare | Freedom Health | Private Medical Insurance (PMI) |APRIL |Aviva Health | CIGNA | CSHealthcare| General & Medical Healthcare | Groupama Healthcare |Health-on-line | Medical Care Direct | PHC| SecureHealth | Tesco Bank | Universal Provident |Videourodynamics | VCMG | Ysbyty Glan Clywd| Bangor | Ysbyty Gwynedd | Universal Provident
      © Copyright Iqbal Shergill 2010 Designed by Medical Media